Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by Unicorn9000on May 29, 2020 11:22am
102 Views
Post# 31087765

RE:RE:RE:NEWS debt repayment 5 cent valuation....

RE:RE:RE:NEWS debt repayment 5 cent valuation....
Magnum2 wrote:

Perfect, now we have 34.76 Million shares of overhang @ 5cts...

In addition, the Companyannounces that it was named in a statement of claim filed January 2019 by Cheryl Farmer, the former Chief Financial Officer of the Company, for wrongful dismissal in the amount of $2.5 million USD. The Company and the plaintiff have come to a satisfactory resolution and Lattice Biologics trusts that Ms. Farmer will have success in her future endeavors.

The Company reserved $600,000 Canadian in its most recent audited financial statements. The settlement includes a severance payment of $100,000 to be paid over 9 months, and 18 million shares at $.05 Canadian. The shares are subject to TSX approval, and all regulatory restrictions.

Lattice Biologics 16.76 million shares for debt 2020-05-28 17:25 ET - Shares for Debt The TSX Venture Exchange has accepted for filing the company's proposal to issue 16.76 million shares at a deemed price of five cents per share to settle outstanding debt for $838,000. Number of creditors: one creditor Insider: Guy Cook, $838,000, 16.76 million shares at five cents The company shall issue a news release when the shares are issued and the debt extinguished.



That's right as MaterialWorld puts it

Guy is no fool. Hahahahaha almost 17 million shares. Is that salary? 

even profitable mid Tier companies in Toronto don't make a third of that. Geez


scary stuff 

<< Previous
Bullboard Posts
Next >>